Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Podcast
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Novo Nordisk's CFO joins “The Top Line” to discuss oral Wegovy’s rollout, the company’s raised outlook and why he’s still optimistic about CagriSema.
Ayla Ellison
,
James Waldron
Aug 7, 2026 8:42am
PacBio CEO steps down amid layoffs, widening Q2 loss
Aug 6, 2026 10:45am
Fierce Pharma
Narcan maker Emergent axes top R&D post in sweeping restructuring
Aug 5, 2026 8:16pm
Smith & Nephew cuts 2026 outlook as US knee implant sales slide
Aug 4, 2026 3:00pm
BMS CEO doesn’t ‘feel any compulsion to chase deals’
Jul 30, 2026 10:37am
Fierce Pharma
BMS delays key Cobenfy, milvexian readouts amid Q2 beat
Jul 30, 2026 10:12am
Fierce Pharma
Fierce Pharma
Fierce Pharma
Fierce Pharma